|
1
|
E BraunwaldRA KlonerMyocardial
reperfusion: a double-edged sword?J Clin
Invest7617131719198510.1172/JCI1121604056048
|
|
2
|
DM YellonDJ HausenloyMyocardial
reperfusion injuryN Engl J
Med35711211135200710.1056/NEJMra07166717855673
|
|
3
|
X LvJ WanJ YangCytochrome P450
omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via
activation of ERK1/2 signaling in rat myocardial
ischemia-reperfusionEur J
Pharmacol596118126200810.1016/j.ejphar.2008.08.00818771665
|
|
4
|
ML EntmanL MichaelRD RossenInflammation in
the course of early myocardial ischemiaFASEB
J52529253719911868978
|
|
5
|
S FrantzL KobzikYD KimToll4 (TLR4)
expression in cardiac myocytes in normal and failing myocardiumJ
Clin Invest104271280199910.1172/JCI670910430608
|
|
6
|
LC HsuJM ParkK ZhangThe protein kinase PKR
is required for macrophage apoptosis after activation of Toll-like
receptor 4Nature428341345200410.1038/nature0240515029200
|
|
7
|
DY JungH LeeBY JungTLR4, but not TLR2,
signals autoregulatory apoptosis of cultured microglia: a critical
role of IFN-beta as a decision makerJ
Immunol17464676476200510.4049/jimmunol.174.10.646715879150
|
|
8
|
SC KimJP SticeL ChenExtracellular heat
shock protein 60, cardiac myocytes, and apoptosisCirc
Res10511861195200910.1161/CIRCRESAHA.109.20964319875724
|
|
9
|
K MiyakeInnate immune sensing of pathogens
and danger signals by cell surface Toll-like receptorsSemin
Immunol19310200710.1016/j.smim.2006.12.00217275324
|
|
10
|
KJ HanX SuLG XuLH BinJ ZhangHB
ShuMechanisms of the TRIF-induced interferon-stimulated response
element and NF-kappaB activation and apoptosis pathwaysJ Biol
Chem2791565215661200410.1074/jbc.M31162920014739303
|
|
11
|
G BaumgartenP KnuefermannN NozakiN
SivasubramanianDL MannJG VallejoIn vivo expression of
proinflammatory mediators in the adult heart after endotoxin
administration: the role of toll-like receptor-4J Infect
Dis18316171624200110.1086/32071211343210
|
|
12
|
J OyamaC Blais JrX LiuReduced myocardial
ischemia-reperfusion injury in toll-like receptor 4-deficient
miceCirculation109784789200410.1161/01.CIR.0000112575.66565.8414970116
|
|
13
|
JA BaurDA SinclairTherapeutic potential of
resveratrol: the in vivo evidenceNat Rev Drug
Discov5493506200610.1038/nrd206016732220
|
|
14
|
MY ShenG HsiaoCL LiuInhibitory mechanisms
of resveratrol in platelet activation: pivotal roles of p38 MAPK
and NO/cyclic GMPBr J Haematol139475485200717868048
|
|
15
|
JG WoodB RoginaS LavuSirtuin activators
mimic caloric restriction and delay ageing in
metazoansNature430686689200410.1038/nature0278915254550
|
|
16
|
PM BritoNF SimoesLM AlmeidaTC
DinisResveratrol disrupts peroxynitrite-triggered mitochondrial
apoptotic pathway: a role for
Bcl-2Apoptosis1310431053200810.1007/s10495-008-0235-418584328
|
|
17
|
G LanzilliA CottarelliG NicoteraS GuidaG
RavagnanMP FuggettaAnti-inflammatory effect of resveratrol and
polydatin by in vitro IL-17 modulationInflammationMar 32011(Epub
ahead of print)
|
|
18
|
S BradamanteL BarenghiF
PiccininiResveratrol provides late-phase cardioprotection by means
of a nitric oxide- and adenosine-mediated mechanismEur J
Pharmacol465115123200310.1016/S0014-2999(03)01441-912650840
|
|
19
|
S DasGA CordisN MaulikDK
DasPharmacological preconditioning with resveratrol: role of
CREB-dependent Bcl-2 signaling via adenosine A3 receptor
activationAm J Physiol Heart Circ
Physiol288H328H335200510.1152/ajpheart.00453.200415345477
|
|
20
|
HS YounJY LeeKA FitzgeraldHA YoungS
AkiraDH HwangSpecific inhibition of MyD88-independent signaling
pathways of TLR3 and TLR4 by resveratrol: molecular targets are
TBK1 and RIP1 in TRIF complexJ
Immunol17533393346200510.4049/jimmunol.175.5.333916116226
|
|
21
|
T RuiQ FengM LeiErythropoietin prevents
the acute myocardial inflammatory response induced by
ischemia/reperfusion via induction of AP-1Cardiovasc
Res65719727200510.1016/j.cardiores.2004.11.01915664399
|
|
22
|
HP ChenM HeQR HuangD LiuM
HuangSasanquasaponin protects rat cardiomyocytes against oxidative
stress induced by anoxia-reoxygenation injuryEur J
Pharmacol5752127200710.1016/j.ejphar.2007.07.04317761161
|
|
23
|
H ReineckeM ZhangT BartosekCE
MurrySurvival, integration, and differentiation of cardiomyocyte
grafts: a study in normal and injured rat
heartsCirculation100193202199910.1161/01.CIR.100.2.19310402450
|
|
24
|
T KoyamaK TemmaT AkeraReperfusion-induced
contracture develops with a decreasing [Ca2+]i in single
heart cellsAm J Physiol261H1115H112219911928393
|
|
25
|
TM ScarabelliA StephanouE PasiniDifferent
signaling pathways induce apoptosis in endothelial cells and
cardiac myocytes during ischemia/reperfusion injuryCirc
Res90745748200210.1161/01.RES.0000015224.07870.9A
|
|
26
|
N MoorjaniS WestabyJ NarulaEffects of left
ventricular volume overload on mitochondrial and
death-receptor-mediated apoptotic pathways in the transition to
heart failureAm J Cardiol10312611268200919406269
|
|
27
|
TV ArumugamSL ChanDG JoGamma
secretase-mediated Notch signaling worsens brain damage and
functional outcome in ischemic strokeNat
Med12621623200610.1038/nm140316680150
|
|
28
|
W ChaoToll-like receptor signaling: a
critical modulator of cell survival and ischemic injury in the
heartAm J Physiol Heart Circ
Physiol296H1H12200910.1152/ajpheart.00995.200819011041
|
|
29
|
J ChaZ WangL AoCytokines link Toll-like
receptor 4 signaling to cardiac dysfunction after global myocardial
ischemiaAnn Thorac
Surg8516781685200810.1016/j.athoracsur.2008.01.04318442564
|
|
30
|
AJ ChongA ShimamotoCR HamptonToll-like
receptor 4 mediates ischemia/reperfusion injury of the heartJ
Thorac Cardiovasc
Surg128170179200410.1016/j.jtcvs.2003.11.03615282452
|
|
31
|
DJ KaczorowskiA NakaoR
VallabhaneniMechanisms of Toll-like receptor 4 (TLR4)-mediated
inflammation after cold ischemia/reperfusion in the
heartTransplantation8714551463200910.1097/TP.0b013e3181a36e5e19461481
|
|
32
|
Y WangAM AbarbanellJL HerrmannToll-like
receptor signaling pathways and the evidence linking toll-like
receptor signaling to cardiac ischemia/reperfusion
injuryShock34548557201010.1097/SHK.0b013e3181e686f520458266
|
|
33
|
RJ CarmodyYH ChenNuclear factor-kappaB:
activation and regulation during toll-like receptor signalingCell
Mol Immunol43141200717349209
|
|
34
|
B SalaunP RomeroS LebecqueToll-like
receptors’ two-edged sword: when immunity meets apoptosisEur J
Immunol37331133182007
|
|
35
|
A ShimamotoAJ ChongM YadaInhibition of
Toll-like receptor 4 with eritoran attenuates myocardial
ischemia-reperfusion injuryCirculation114Suppl
1S270274200610.1161/CIRCULATIONAHA.105.00090116820585
|
|
36
|
J DudleyS DasS MukherjeeDK DasResveratrol,
a unique phytoalexin present in red wine, delivers either survival
signal or death signal to the ischemic myocardium depending on
doseJ Nutr Biochem20443452200910.1016/j.jnutbio.2008.05.003
|
|
37
|
S MukherjeeJI DudleyDK DasDose-dependency
of resveratrol in providing health benefitsDose
Response8478500201010.2203/dose-response.09-015.Mukherjee21191486
|
|
38
|
DK DasN MaulikResveratrol in
cardioprotection: a therapeutic promise of alternative medicineMol
Interv63647200610.1124/mi.6.1.716507749
|
